Page last updated: 2024-10-29

isoproterenol and Movement Disorders

isoproterenol has been researched along with Movement Disorders in 1 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dill, RE1

Other Studies

1 other study available for isoproterenol and Movement Disorders

ArticleYear
Mescaline: receptor interaction in the rat striatum.
    Archives internationales de pharmacodynamie et de therapie, 1972, Volume: 195, Issue:2

    Topics: Animals; Basal Ganglia; Behavior, Animal; Caudate Nucleus; Chlorpromazine; Cyclic AMP; Dopamine; Dru

1972